$TRUP

GALLAGHER JOHN R sold $11K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 431 shares of TRUPANION, INC. (TRUP) at $25.08 on 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jul 30, 2026, 9:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 9:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
low confidence
Mentioned
$TRUP
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The only new fact is the COO’s open-market sale details (431 shares at $25.08) under a pre-arranged 10b5-1 plan; no operational or financial guidance changes are provided.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure reduces fundamental interpretability.

03

What to watch

The article does not state total position value, prior sale cadence, or whether other insiders sold/bought around the same window, which limits inference from a single transaction.

Relevance 2/10Novelty 2/10Timing: filed 2026-07-30, sale dated 2026-07-28

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC.

Company-level read

Ticker impact

$TRUPNeutralLow confidence
Context

TRUP insider Form 4 shows COO John R. Gallagher sold 431 shares at $25.08 on 2026-07-28 under a 10b5-1 plan.

Expected impact

Likely minimal price impact; any reaction would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a scheduled open-market sale under a pre-arranged 10b5-1 plan, with no accompanying guidance, operational update, or enforcement/regulatory event disclosed.

Market effects

No clear sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Because it is a 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations, so traders may overreact if they treat it as discretionary selling.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction is disclosed on SEC Form 4.

  • GALLAGHER JOHN R

    Chief Operating Officer who sold 431 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended